| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/16/2008 | CN101163669A Acetylene derivatives |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101161644A Hydroxy nidazole compound and preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381418C Gelling agents |
| 04/15/2008 | US7358393 Method for preparing β-alaninamides |
| 04/15/2008 | US7358369 Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives |
| 04/15/2008 | US7358365 Process for the controlled increase in the molecular weight of polyethylenes |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358269 selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; pain |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/15/2008 | US7358238 3-(2-Phenoxymethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]azepin-9-one; inhibiting the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1); increase intracellular concentration of active glucocorticoid; metabolic disorders, insulin resistance, dyslipidemia, obesity |
| 04/10/2008 | WO2008042282A2 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | US20080083606 Separation of acids from chemical reaction mixtures by means of ionic liquids |
| 04/10/2008 | CA2663856A1 Jak-2 modulators and methods of use |
| 04/09/2008 | EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
| 04/09/2008 | EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation |
| 04/09/2008 | EP1907347A2 Compounds with activity at retinoic acid receptors |
| 04/09/2008 | EP1461320B1 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | CN101160282A Acetylene derivatives |
| 04/09/2008 | CN101157656A Method for producing cimetidine |
| 04/09/2008 | CN101157655A Method for synthesizing (4S,5R)- half-ester |
| 04/09/2008 | CN100379728C Novel imidazole compounds, method for preparing same and use thereof as medicines |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/03/2008 | WO2008039794A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008038098A1 Crystalline form of 7 [5-cyclopropyl)-4-o-fluorobenzylcarbamoyl)-2-(4-fluorophenyl)-imidazol-1-yl]-3r,5r-dihydroxyheptanoic |
| 04/03/2008 | WO2008038042A1 Chemical process for displacing nitro groups |
| 04/03/2008 | WO2008038031A1 An improved process for the preparation of temozolomide and analogs |
| 04/03/2008 | WO2008014291A3 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | US20080081831 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor |
| 04/03/2008 | CA2664052A1 An improved process for the preparation of temozolomide and analogs |
| 04/02/2008 | EP1905763A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 04/02/2008 | EP1904592A1 Phenylazo-acetoacetanilide derivatives with a polymer! zable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks |
| 04/02/2008 | EP1904465A1 Method of synthesis of imidazole-amino acid derivatives and related compounds |
| 04/02/2008 | CN101155784A Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 04/02/2008 | CN101155777A Method for producing disulfonyl fluride compound |
| 04/02/2008 | CN101153028A Compounds with antimicrobial antiviral activity |
| 04/02/2008 | CN101153025A Pyrethroid compounds |
| 04/02/2008 | CN101153024A Aryl substituted imidazoline-2-ketones derivant, producing method and uses of the same |
| 04/02/2008 | CN100378080C Precursor of Lisinopril compound and synthesizing method |
| 04/02/2008 | CN100378056C Luminous compounds and labeling reagents using the same |
| 04/01/2008 | US7351836 Antiinflammatory agents |
| 04/01/2008 | US7351835 Organic molecular cataylst having binaphthol skeleton and processes for producing the same and application thereof |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351429 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide as an active ingredient, excipient, binder, lubricant and coating agent; uniform in the content of a small amount of active ingredient, excellent light stability; anticholinergic activity on bladder and drug for pollakiuria and urinary incontinence |
| 04/01/2008 | US7351339 Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids |
| 03/27/2008 | WO2008036084A1 Synthesis of 1,3 disubstituted imidazolium salts |
| 03/27/2008 | WO2008035796A1 Method for producing high-purity quaternary ammonium salt |
| 03/27/2008 | WO2008034891A2 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | WO2008034650A1 Composition for dyeing keratin fibres, comprising a cationic diazo direct dye containing a 2-imidazolium unit |
| 03/27/2008 | WO2008004088A3 Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding |
| 03/27/2008 | US20080076932 A process for the preparation of phenyltetrazole compounds |
| 03/27/2008 | US20080076809 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses |
| 03/27/2008 | US20080076770 -[4-(4,5-dichloro-1H-imidazol-1-yl)-phenyl]-3-(4-trifluoromethyl-phenyl)-urea; useful for treating hypertensive, cardiovascular, inflammatory, and diabetes related diseases |
| 03/27/2008 | DE102007040919A1 Producing polymers by polymerizing olefinic monomers in the liquid phase in the presence of an ionic liquid catalyst comprises using a pyrazolium salt as the catalyst |
| 03/27/2008 | CA2663635A1 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | CA2603705A1 A process for the preparation of phenyltetrazole compounds |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1903035A2 High purity butoconazole nitrate with specified particle size and a process for preparation of thereof |
| 03/26/2008 | EP1902035A1 Method for the production of onium alkyl sulfites |
| 03/26/2008 | EP1902022A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 03/26/2008 | EP1902020A1 Derivatives of seleno-amino acids |
| 03/26/2008 | EP1902004A2 Onium-alkylsulfonate production method |
| 03/26/2008 | CN101148438A Method for synthesizing derivative 4-[(2,4-Dioxo-imidazolidin-1-ylimino)-methyl]-benzoic acid of 1-amino-imidazolidine-2,4-dione |
| 03/26/2008 | CN100376584C Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof |
| 03/26/2008 | CN100376559C Method for preparing secnidazole |
| 03/26/2008 | CN100376324C Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
| 03/25/2008 | US7348425 Inhibitors of HCV replication |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348317 Aqueous compositions containing metronidazole |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008033836A2 Process and intermediates for preparing integrase inhibitors |
| 03/20/2008 | WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 03/20/2008 | WO2008032585A2 Cyclopropanecarboxylates and use thereof as pesticides |
| 03/20/2008 | WO2008031199A1 Ionic compounds having bronsted acidity and uses thereof |
| 03/20/2008 | WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor |
| 03/20/2008 | WO2008012470A3 Substituted imidazolone derivatives, preparation and uses |
| 03/20/2008 | WO2008005906A3 Fluid storage and purification method and system using ionic liquid in particular di-imidazolium cation |
| 03/20/2008 | WO2007149874A8 Imidazolidinone kv1.5 potassium channel inhibitors |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | CA2661943A1 Process and intermediates for preparing integrase inhibitors |
| 03/19/2008 | EP1899305A1 Helix 12 directed non-steroidal antiandrogens |
| 03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/19/2008 | CN101143849A Preparation and purification method for optical enantiomer of ornidaxole |
| 03/19/2008 | CN101143848A Imidazole-like ionic salt with electron donor-acceptor structure, preparation method and use thereof |
| 03/19/2008 | CN100375747C Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates |